We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.56T
1-Year Est. Return 27.86%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
-12.89%
1 Year Est. Return
+27.86%
3 Year Est. Return
+90.49%
5 Year Est. Return
+115.47%
10 Year Est. Return
+468.9%
AUM
$432B
AUM Growth
-$89.7B
Cap. Flow
-$17.1B
Cap. Flow %
-3.95%
Top 10 Hldgs %
15.74%
Holding
6,191
New
487
Increased
2,559
Reduced
2,219
Closed
424

Sector Composition

Rank Sector Weight
1 Financials 12.46%
2 Technology 11.62%
3 Healthcare 10.99%
4 Consumer Discretionary 8.24%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDXS icon
4376
Codexis
CDXS
$151M
$219K ﹤0.01%
13,090
-5,549
-30% -$95.8K
MRTX
4377
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$219K ﹤0.01%
5,152
+480
+10% +$19.1K
MLNT
4378
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$219K ﹤0.01%
55,261
-42,246
-43% -$540K
EMCI
4379
DELISTED
EMC INS Group Inc
EMCI
$219K ﹤0.01%
6,886
+217
+3% +$6.02K
DMRC icon
4380
Digimarc Corp
DMRC
$147M
$218K ﹤0.01%
14,993
+12,397
+478% +$272K
OFLX icon
4381
Omega Flex
OFLX
$297M
$217K ﹤0.01%
4,025
+3,351
+497% +$199K
SMMV icon
4382
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$289M
$217K ﹤0.01%
+7,454
New +$230K
KINS icon
4383
Kingstone Companies
KINS
$289M
$216K ﹤0.01%
12,184
+2,797
+30% +$46.8K
HAPN
4384
Happen Inc
HAPN
$2.21B
$216K ﹤0.01%
16,406
-58,075
-78% -$958K
STNG icon
4385
Scorpio Tankers
STNG
$3.9B
$216K ﹤0.01%
12,278
+4,919
+67% +$91.6K
EPZM
4386
CALL
DELISTED
Epizyme, Inc
EPZM
$216K ﹤0.01%
35,000
-5,000
-13% -$38.2K
EPZM
4387
PUT
DELISTED
Epizyme, Inc
EPZM
$216K ﹤0.01%
35,000
-5,000
-13% -$38.2K
MACK
4388
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$216K ﹤0.01%
71,092
+1,068
+2% +$3.7K
IQDF icon
4389
FlexShares International Quality Dividend Index Fund
IQDF
$1.15B
$215K ﹤0.01%
10,225
+225
+2% +$5.02K
UEIC icon
4390
Universal Electronics
UEIC
$57.8M
$215K ﹤0.01%
8,523
+2,031
+31% +$65.7K
NBRV
4391
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$215K ﹤0.01%
588
-51
-8% -$27.4K
OMF icon
4392
OneMain Financial
OMF
$7.2B
$214K ﹤0.01%
8,817
-2,003
-19% -$57K
TRUE
4393
DELISTED
TrueCar
TRUE
$214K ﹤0.01%
23,630
-399,838
-94% -$4.32M
FNJN
4394
DELISTED
Finjan Holdings, Inc.
FNJN
$214K ﹤0.01%
85,334
-297,888
-78% -$996K
CEF icon
4395
Sprott Physical Gold and Silver Trust
CEF
$7.4B
$210K ﹤0.01%
16,700
+10,215
+158% +$121K
IEUS icon
4396
iShares MSCI Europe Small-Cap ETF
IEUS
$180M
$209K ﹤0.01%
4,648
+58
+1% +$2.84K
WLDN icon
4397
Willdan Group
WLDN
$1.04B
$209K ﹤0.01%
5,971
+4,151
+228% +$142K
WRLD icon
4398
World Acceptance Corp
WRLD
$838M
$209K ﹤0.01%
2,047
-26,331
-93% -$2.71M
RCM
4399
DELISTED
R1 RCM Inc. Common Stock
RCM
$209K ﹤0.01%
26,294
-181,032
-87% -$1.56M
CVRR
4400
DELISTED
CVR Refining, LP
CVRR
$209K ﹤0.01%
20,020
+4,830
+32% +$75.9K

Similar funds

JP Morgan Chase's Q4 2018 Portfolio in Review

As of Q4 2018, JP Morgan Chase held 6,191 positions worth $432B, down 17% from $522B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

JP Morgan Chase withdrew a net $17.1B in Q4 2018, closing 424 positions and reducing 2,219 holdings. Its most notable exit was Energen, an estimated $648M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, JP Morgan Chase opened a new position in Linde worth $751M.

  • JP Morgan Chase's largest Q4 2018 buy was Linde: 4,813,392 shares worth $751M.
  • JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2018, an estimated $1.56B increase.
  • JP Morgan Chase's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.82B.
  • JP Morgan Chase fully exited Energen in Q4 2018, selling an estimated $648M.
  • JP Morgan Chase's ten largest holdings make up 16% of its $432B portfolio in Q4 2018.
  • JP Morgan Chase opened 487 new positions and closed 424 in Q4 2018.
  • JP Morgan Chase's portfolio value fell 17% quarter-over-quarter to $432B.

Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.